Rabies in humans: A treatment approach
Higher-dosed treatments with monoclonal antibodies in serum may be needed to yield an effect. Any experimental treatment may be most promising in patients who have other factors associated with survival. In the absence of these, initiation of palliative care still seems to remain the most rational strategy.
Authors
- Eleonora Aronica (ORCID: https://orcid.org/0000-0002-3542-3770)
- Matthijs C. Brouwer (ORCID: https://orcid.org/0000-0001-7775-7843)
- Ron A. A. Mathôt (ORCID: https://orcid.org/0000-0001-8401-0879)
- Cornelis A. De Pijper
- Corine H. GeurtsvanKessel (ORCID: https://orcid.org/0000-0002-7678-314X)
- Abraham Goorhuis (ORCID: https://orcid.org/0000-0001-7423-6217)
- Janke Schinkel (ORCID: https://orcid.org/0000-0002-1112-0644)
- Menno D. de Jong (ORCID: https://orcid.org/0000-0002-8380-4738)
- Martin P. Grobusch
- Nicole P. Juffermans (ORCID: https://orcid.org/0000-0002-3039-6574)
- Diederik van de Beek (ORCID: https://orcid.org/0000-0002-4571-044X)
- P. P. A. M. van Thiel
Institutions
- Erasmus MC (NL)
- Amsterdam Neuroscience (NL)
- Amsterdam University Medical Centers (NL)
- Institute of Infection and Immunity (CA)
- University of Amsterdam (NL)
- Erasmus University Rotterdam (NL)
Publication Details
- Journal
- Travel Medicine and Infectious Disease
- Published
- 2025-02-07
- DOI
- https://doi.org/10.1016/j.tmaid.2025.102813
- Citations
- 4
- Primary Topic
- Rabies epidemiology and control
- Type
- article
- Field-Weighted Citation Impact
- 4.15